螺旋CT多功能重建在骨关节外伤中的应用

目的 探讨螺旋cT功能重建在骨与关节外伤中的应用，提高重建技术的使用能力和诊断水平。方法 对使用双层螺旋CT，SSD，MPR，MIP等多种方式重建检查的49例复杂的骨与关节外伤病例进行回顾性分析。结果 49例骨关节外伤重建成像，其中，颅底3例，颌面部7例，颈、胸、腰、骶椎共17例，肩胛骨3例，髋关节8例，膝关节11例。SSD在显示碎骨片明显移位的空间关系方面较MIP，MPR为佳，它可以直观地、立体地、清晰地、多角度显示骨关节损伤，而MIP在显示骨折细节方面较优，尤其在外伤中颅窝观察有关神经孔方面。结论 螺旋CT的SSD，MPR和MIP技术的综合应用，对复杂的骨折、关节损伤的显示效果良好，具有较高的临床应用价值。     

Depressive symptom deterioration in a large primary care-based elderly cohort.

OBJECTIVE: The purpose of this study is to examine the incidence and clinical predictors of symptom deterioration in depressed elderly patients who have responded to treatment in primary care. METHOD: A cohort study of 901 older adults from 18 primary care clinics in five states who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for major depression and/or dysthymia at baseline interview, had participated in a trial of collaborative care for depression compared to usual care, and had improved to the point of no longer meeting criteria for major depression at 12 months were observed for one year (18 and 24 months) after enrolling in the original study. RESULTS: A total of 40% of patients met criteria for significant depressive symptom deterioration over the 12- to 24-month observational period. Among usual-care patients, higher initial severity of depression and a higher number of residual DSM-IV depressive symptoms at 12 months were significant predictors of symptom deterioration. No variables predicted symptom deterioration in intervention patients. CONCLUSIONS: There is a high rate of symptom deterioration among elderly patients in primary care who are treated for depression. Efforts to improve long-term outcomes of older patients with major depression and/or dysthymia should focus on providing more intensive treatment and follow up for patients with residual depressive symptoms.     

聚苯醚热固性改性及其性能研究

通过溴化聚苯醚和格利雅试剂反应，将不饱和基团烯丙基引入聚苯醚中实现其热固性改性，由^1H-NMR和FTIR进行结构表征。确定了烯丙化聚苯醚的固化工艺，并对其固化产物性能进行测试。结果表明：按合成新工艺制备的热固性聚苯醚，其固化产物具有优异的介电性能(低介电常数、低介电损耗因子)，良好的耐溶剂性能和低吸湿性。     

儿茶酚胺对小鼠皮肤导电性的影响

研究了外源性儿茶酚胺对小鼠皮肤导电性的影响。结果表明,肾上腺素、去甲肾上腺素和异丙肾上腺素均可使皮肤导电性明显增加,而苯肾上腺素则能使皮肤导电性下降。     

Ⅱ型肾病综合征血脂、脂蛋白变化及其相关因素研究

本文观察15例Ⅱ型肾病综合征血脂、脂蛋白,与20例正常人比较。结果病人TC、TG、LDL-C显著增高,HDL_2-C显著降低,同时发现病人RC,TG,LDL-C与血白蛋白呈显著负相关,血脂、脂蛋白与血肌酐呈轻度正相关。提示Ⅱ型肾病综合征存在广泛脂质及脂蛋白异常,是并发心血管疾病及肾脏病恶化的危险因素。     

股骨头缺血坏死的低场MRI评价

目的: 分析股骨头缺血坏死(ANFH)低场MRI征象,评价ANFH的MRI分期及其关节积液的分级.材料和方法:在分析50例正常髋MRI基础上回顾性对照分析51例(90个股骨头)ANFH的低场MRI和X线平片资料.结果:90个ANFH中,20个(22 %) X线平片为阴性;64个(71%)MRI示"脂肪强度征"即坏死区内或近侧可见类似皮下脂肪样信号.按照 Hungerford分期:0期9个,Ⅰ期13个,Ⅱ期31个,Ⅲ期26个,Ⅳ期11个.ANFH引起的关节积液多为2～3级(60个髋,占67%);Ⅲ、Ⅳ期ANFH合并关节积液量比0～Ⅱ期明显多(P＜0.005).结论:低场MRI能够准确显示ANFH的范围、程度、信号特征及其关节积液的情况,并能够对早期ANFH作出可靠诊断;"脂肪强度征"为低场MRI的特征性表现,对诊断ANFH有非常重要的价值.     

聚偏氟乙烯支撑液膜萃取乳酸

采用聚偏氟乙烯固体微孔膜,与溶解在煤油中的三烷基氧磷组成支撑液膜(SLM),分离稀水溶液中的乳酸。考察了pH值、料液浓度、载体浓度、温度、料液及解析液流量对传质速率的影响。同时进行了膜稳定性的定性研究。发现乳酸以分子形式通过SLM;载体浓度为40%时传质速率最大;SLM对乳酸的通量与稀水溶液中乳酸浓度成正比。料液和解析液预先用有机相饱和时,膜的稳定性可大大改善。     

胸腰椎爆裂骨折椎管内骨片侵入倾向与对策

根据98例中获得随访的39例的X线、CT和MRI(24例)影像学资料,分析胸腰椎爆裂骨折椎管内骨片侵入倾向及对策。将爆裂骨折侵入椎管分为四类八型,宜采用Harrington器械钢丝或椎弓根螺钉钢板轴向撑开系统,使骨折复位,椎管容积恢复,毋需行后路椎管减压。本组取得良好效果。仅对骨片游离型需要切开椎管直接摘除骨片。     

疱疹样脓疱病七例报告

报告7例疱疹样脓疱病,并分析指出本病发生与妊娠、低血钙无明显关系,同意该病区别于典型的泛发性脓疱性银屑病。雷公藤单用或并用皮质激素有较好效果,亦应重视雷公藤的副作用。     

Can Small Hepatocellular Carcinoma be Cured by Percutaneous Acetic Acid Injection Therapy?

To assess the efficacy of ultrasound (US)-guided percutaneous acetic acid (in concentrations of 15%, 20%, 30%, 40%, and 50%) injection for small hepatocellular carcinomas (HCCs) for long-term prognosis, percutaneous acetic acid injection using 15% to 50% acetic acid was performed in 91 patients with one to four HCCs smaller than 3 cm during the past 6.5 years. During the series of treatment sessions for each patient, the same concentration of acetic acid was used. All tumors could be treated successfully with percutaneous acetic acid injection despite the differences in acetic acid concentration used. The number of treatment sessions to treat similar size of tumor was less when the higher concentration of acetic acid was used. No serious complications occurred as a direct sequela to percutaneous acetic acid injection. None of the tumor treated regrew. The 1-, 2-, 3-, 4-, and 5-year survival rates for 91 patients were 95%, 87%, 80%, 63%, and 49%, respectively. The 1-, 2-, 3-, 4-, and 5-year cancer-free survival rates of these patients were 83%, 54%, 50%, 37%, and 29%, respectively. Both liver function and size of tumor affected both survival rate and cancer-free survival rate significantly, but the number of tumors did not. The concentration of acetic acid did not affect the survival rate. Percutaneous acetic acid using 15% to 50% acetic acid will be effective therapy for small HCCs for long-term prognosis.